Anti-SLC2A2 (GLUT2) (Human) pAb
Anti-SLC2A2 (GLUT2) (Human) pAb Specifications
|Background:||Members of the solute carrier family 2 are classified as facilitative glucose transporters (GLUTs), which transport glucose into most cells. SLC2A2/GLUT2 is predominantly expressed in the liver and weakly expressed in the kidney and small intestine. Mice in which the slc2a2 gene is deleted are hyperglycemic and hypoinsulinemic; they have elevated plasma levels of glucagons, free fatty acids, and Ã¯ÂÂ¢-hydroxybutyrate. Truncated forms of SLC2A2/GLUT2 that result from gene mutation are detected in patients with Fanconi-Bickel syndrome; this condition is characterized by hepatorenal glycogen accumulation, proximal renal tubular dysfunction, and impaired carbohydrate metabolism, possibly caused by dysfunction of the truncated SLC2A2/GLUT2.
|Formulation:||In PBS/50% glycerol, pH 7.2|
|Gene ID Human:||6514|
|Gene ID Mouse:||20526|
|Immunogen:||Human SLC2A2-derived synthetic peptide|
|Regulatory Statement:||For Research Use Only. Not for use in diagnostic procedures.|
|Product Type:||Primary Antibody|
Applications: FCM, IH
|IHC:||1:2500（Heat treatment is necessary for paraffin em|
There are no references for Anti-SLC2A2 (GLUT2) (Human) pAb at this time.